Vyome Holdings (HIND) Return on Equity [ROE] (2017 - 2026)
Vyome Holdings (HIND) reported Return on Equity [ROE] of -150.85% for Q2 2026, up 38.40 percentage points from the prior quarter.
Powered by 
Analysis
Vyome Holdings (HIND) Return on Equity [ROE] (2017 - 2026) Analysis & Trends
For FY2022, Vyome Holdings posted Return on Equity [ROE] of -192.58%, up 22.12 percentage points from FY2021.
- Return on Equity [ROE] has a five-year change of -123.39 percentage points (FY2017 to FY2022).
- By year, Return on Equity [ROE] came in at -214.70% in FY2021 (-102.61 pp), -112.09% in FY2020 (+12.76 pp), -124.85% in FY2019 (+28.47 pp) and -153.32% in FY2018 (-84.13 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q4 2021.
- The high point for year-over-year Return on Equity [ROE] in five years was Q3 2021 (a gain of 52.94 percentage points); the low point was Q1 2023 (a drop of 549.94 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Vyome Holdings | 13.41 Mn | -12.70 Mn | 11,658.00 | -150.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -150.85% |
| Mar 31, 2026 | -189.26% |
| Dec 31, 2025 | -272.84% |
| Sep 30, 2023 | -532.70% |
| Jun 30, 2023 | -479.76% |
| Mar 31, 2023 | -713.27% |
| Dec 31, 2022 | -408.39% |
| Sep 30, 2022 | -269.29% |
| Jun 30, 2022 | -212.42% |
| Mar 31, 2022 | -163.33% |
| Dec 31, 2021 | -102.14% |
| Sep 30, 2021 | -50.10% |
| Jun 30, 2021 | -63.46% |
| Mar 31, 2021 | -163.21% |
| Dec 31, 2020 | -140.83% |
| Sep 30, 2020 | -103.04% |
| Jun 30, 2020 | -84.63% |
| Mar 31, 2020 | -87.75% |
| Dec 31, 2019 | -105.18% |
| Sep 30, 2019 | -189.27% |
API Access
Vyome Holdings Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HIND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "HIND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HIND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();